Shots:
CDMOs have become central to the modern biopharmaceutical ecosystem, helping companies accelerate development timelines, navigate rising technical complexity, and bring innovative therapies to market with greater efficiency
The global CDMO market continues to post strong double-digit growth and is projected to reach nearly $255B by 2025. This momentum is driven by increased outsourcing, the…
Shots:
Pharmaceutical manufacturing involves complex procedures like blending, compression, filtration, heating, encapsulation, shearing, tableting, granulation, coating, and drying. Traditionally, for all these processes, pharma companies had designated factory floors to carry out the process smoothly
The flexible manufacturing system (FMS) revolutionized the course of manufacturing, especially in the pharma industry. Contract Development Manufacturing Organizations' (CDMOs)…
The first quarter of 2022 highlights the approvals, clinical data & acquisitions. There are major alliances in this quarter which include Biocon acquired Viatris’ biosimilars assets for ~$3.335B, Stryker signed a definitive agreement to acquire Vocera Communications for ~$3.09B, Biohaven acquire Channel Biosciences for ~$3B
The first quarter of the year also showcases regulatory events…

